Preferred Label : delgocitinib;

MeSH synonym : 3-((3S,4R)-3-methyl-6-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1,6-diazaspiro(3.4)octan-1-yl)-3-oxopropanenitrile; 1,6-Diazaspiro(3.4)octane-1-propanenitrile, 3-methyl-beta-oxo-6-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-, (3S,4R)-;

UNII : 9L0Q8KK220;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3603177/fr/anzupgo-delgocitinib-eczema-chronique-des-mains-ecm
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, cutaneous
delgocitinib
Chronic hand eczema (disorder)
chronic disease
Janus Kinase Inhibitors
adult
evaluation of the transparency committee
delgocitinib
eczema
hand

---
https://www.ema.europa.eu/en/medicines/human/EPAR/anzupgo
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
delgocitinib
delgocitinib
drug approval
europe
delgocitinib
hand dermatoses
eczema
chronic disease
Chronic hand eczema (disorder)
adult
administration, cutaneous
Janus Kinase Inhibitors
Janus Kinase Inhibitors
product surveillance, postmarketing
pregnancy
breast feeding
drug evaluation, preclinical

---
Nous contacter.
03/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.